🇺🇸 FDA
Patent

US 7728006

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

granted A61KA61K31/4709A61K9/0019

Quick answer

US patent 7728006 (Quinolinone-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4709, A61K9/0019, A61K9/0075, A61K9/008